Close Menu

Ohio-Bound

High-tech startups are popping up in unexpected cities, reports the Wall Street Journal. Instead of flocking to Boston or the Bay Area, companies are opening up or remaining in Ohio and Michigan. The founder of Proxy Biomedical Peter Gingras, based in Galway, Ireland, turned to Cleveland to open his US-based operations. "The State of Ohio, the City of Cleveland and the Cleveland Clinic stepped up and put a competitive package together. In the end, it was an easy decision," Gingras says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.